skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: autor: Papp, Kim remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Langley, Richard G ; Elewski, Boni E ; Lebwohl, Mark ; Reich, Kristian ; Griffiths, Christopher E.M ; Papp, Kim ; Puig, Lluís ; Nakagawa, Hidemi ; Spelman, Lynda ; Sigurgeirsson, Bárður ; Rivas, Enrique ; Tsai, Tsen-Fang ; Wasel, Norman ; Tyring, Stephen ; Salko, Thomas ; Hampele, Isabelle ; Notter, Marianne ; Karpov, Alexander ; Helou, Silvia ; Papavassilis, Charis

The New England journal of medicine, 2014-07, Vol.371 (4), p.326-338 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
2
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

Lebwohl, Mark ; Strober, Bruce ; Menter, Alan ; Gordon, Kenneth ; Weglowska, Jolanta ; Puig, Lluis ; Papp, Kim ; Spelman, Lynda ; Toth, Darryl ; Kerdel, Francisco ; Armstrong, April W ; Stingl, Georg ; Kimball, Alexa B ; Bachelez, Herve ; Wu, Jashin J ; Crowley, Jeffrey ; Langley, Richard G ; Blicharski, Tomasz ; Paul, Carle ; Lacour, Jean-Philippe ; Tyring, Stephen ; Kircik, Leon ; Chimenti, Sergio ; Callis Duffin, Kristina ; Bagel, Jerry ; Koo, John ; Aras, Gary ; Li, Joanne ; Song, Wenjie ; Milmont, Cassandra E ; Shi, Yifei ; Erondu, Ngozi ; Klekotka, Paul ; Kotzin, Brian ; Nirula, Ajay

The New England journal of medicine, 2015-10, Vol.373 (14), p.1318-1328 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

Gordon, Kenneth B ; Strober, Bruce ; Lebwohl, Mark ; Augustin, Matthias ; Blauvelt, Andrew ; Poulin, Yves ; Papp, Kim A ; Sofen, Howard ; Puig, Lluís ; Foley, Peter ; Ohtsuki, Mamitaro ; Flack, Mary ; Geng, Ziqian ; Gu, Yihua ; Valdes, Joaquin M ; Thompson, Elizabeth H Z ; Bachelez, Hervé

The Lancet (British edition), 2018-08, Vol.392 (10148), p.650-661 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

Papp, Kim A ; Leonardi, Craig ; Menter, Alan ; Ortonne, Jean-Paul ; Krueger, James G ; Kricorian, Gregory ; Aras, Girish ; Li, Juan ; Russell, Chris B ; Thompson, Elizabeth H.Z ; Baumgartner, Scott

The New England journal of medicine, 2012-03, Vol.366 (13), p.1181-1189 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

Gordon, Kenneth B ; Blauvelt, Andrew ; Papp, Kim A ; Langley, Richard G ; Luger, Thomas ; Ohtsuki, Mamitaro ; Reich, Kristian ; Amato, David ; Ball, Susan G ; Braun, Daniel K ; Cameron, Gregory S ; Erickson, Janelle ; Konrad, Robert J ; Muram, Talia M ; Nickoloff, Brian J ; Osuntokun, Olawale O ; Secrest, Roberta J ; Zhao, Fangyi ; Mallbris, Lotus ; Leonardi, Craig L

The New England journal of medicine, 2016-07, Vol.375 (4), p.345-356 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
6
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Papp, Kim A, Dr ; Langley, Richard G, MD ; Lebwohl, Mark, Prof ; Krueger, Gerald G, Prof ; Szapary, Philippe, MD ; Yeilding, Newman, MD ; Guzzo, Cynthia, MD ; Hsu, Ming-Chun, PhD ; Wang, Yuhua, PhD ; Li, Shu, MS ; Dooley, Lisa T, DrPH ; Reich, Kristian, Prof

The Lancet (British edition), 2008-05, Vol.371 (9625), p.1675-1684 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

Papp, Kim A ; Blauvelt, Andrew ; Bukhalo, Michael ; Gooderham, Melinda ; Krueger, James ; Lacour, Jean-Philippe ; Menter, Alan ; Philipp, Sandra ; Sofen, Howard ; Tyring, Stephen ; Berner, Beate R ; Visvanathan, Sudha ; Pamulapati, Chandrasena ; Bennett, Nathan ; Flack, Mary ; Scholl, Paul ; Padula, Steven J

The New England journal of medicine, 2017-04, Vol.376 (16), p.1551-1560 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
8
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

Menter, Alan, MD ; Tyring, Stephen K., MD, PhD, MBA ; Gordon, Kenneth, MD ; Kimball, Alexa B., MD, MPH ; Leonardi, Craig L., MD ; Langley, Richard G., MD ; Strober, Bruce E., MD, PhD ; Kaul, Martin, MD ; Gu, Yihua, MS ; Okun, Martin, MD, PhD ; Papp, Kim, MD

Journal of the American Academy of Dermatology, 2008, Vol.58 (1), p.106-115 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
9
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis

Menter, Alan, MD ; Feldman, Steven R., MD, PhD ; Weinstein, Gerald D., MD ; Papp, Kim, MD, PhD ; Evans, Robert, PharmD ; Guzzo, Cynthia, MD ; Li, Shu, MS ; Dooley, Lisa T., DrPH ; Arnold, Cynthia, BS ; Gottlieb, Alice B., MD, PhD

Journal of the American Academy of Dermatology, 2007, Vol.56 (1), p.31.e1-31.e15 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
10
Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

Deodhar, Atul ; Gottlieb, Alice B ; Boehncke, Wolf-Henning ; Dong, Bin ; Wang, Yuhua ; Zhuang, Yanli ; Barchuk, William ; Xu, Xie L ; Hsia, Elizabeth C ; AELION, Jacob ; AMARELO-RAMOS, Juan ; BALSA, Alejandro ; BERGHEA, Florian ; BRZEZICKI, Jan ; BURNETTE, Michael ; FRETZIN, Scott ; GARCÍA-CARAZO, Sara ; GLADSTEIN, Geoffrey ; GOMEZ-REINO, Juan ; GOODERHAM, Melinda ; GONZÁLEZ-FERNÁNDEZ, Carlos ; GOTTLIEB, Alice ; GRATACOS, Jordi ; HAALAND, Derek ; KAMALOVA, Rima ; LESZCZYNSKI, Piotr ; MARTIN-MOLA, Emilio ; MASLYANSKY, Alexey ; NAVARRO, Federico ; OPRIS, Daniela ; PAPP, Kim ; PERLAMUTROV, Yuriy ; PHILIPP, Sandra ; RACEWICZ, Artur ; REBROV, Andrey ; RELL-BAKALARSKA, Maria ; ROSMARIN, David ; RUBBERT-ROTH, Andrea ; SHERGY, William ; SHIRINSKY, Ivan ; SONIN, Dmitry ; STANISLAV, Marina ; SUKHAREV, Alexey ; TEMNIKOV, Vadim ; VINOGRADOVA, Irina ; WAYTZ, Paul ; YAKUSHEVICH, Vladimir

The Lancet (British edition), 2018-06, Vol.391 (10136), p.2213-2224 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (127)
  2. Revistas revisadas por pares (123)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (130)
  2. Anais de Congresso  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2006  (11)
  2. 2006Até2009  (23)
  3. 2010Até2013  (24)
  4. 2014Até2018  (35)
  5. Após 2018  (38)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.